Figure 4
From: Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients
IgG antibodies kinetics against SARS-CoV-2 nucleocapsid protein (N) according to the disease severity, age and sex. (a) The kinetics of IgG antibodies against SARS-CoV-2 nucleocapsid protein (N) in asymptomatic, mild, moderate, and severe patients' groups. (b) The kinetics of IgG antibodies against SARS-CoV-2 nucleocapsid protein (N) according to age within < 35; 35–47, 48–59, ≥ 60 groups. (c) The kinetics of IgG antibodies against SARS-CoV-2 nucleocapsid protein (N) antibodies in males (green) and females (pink).
